Your weight-loss drugs set to become cheaper
NEW DELHI: The country’s anti-obesity market is headed for a pricing shake-up, with a clutch of pharma companies readying plans to launch affordable versions of the blockbuster weight-loss medicines Wegovy and Ozempic. This follows the expiry of the patent of semaglutide, the key ingredient in these injectable medications, on March 20, clearing the entry of…